BlackRock’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $465M | Buy |
18,774,530
+147,749
| +0.8% | +$3.52M | 0.01% | 1164 |
|
|
2025
Q4 | $435M | Buy |
18,626,781
+410,721
| +2% | +$9.15M | 0.01% | 1215 |
|
|
2025
Q3 | $359M | Sell |
18,216,060
-684,378
| -4% | -$14.1M | 0.01% | 1297 |
|
|
2025
Q2 | $410M | Buy |
18,900,438
+96,103
| +0.5% | +$2.27M | 0.01% | 1183 |
|
|
2025
Q1 | $456M | Sell |
18,804,335
-620,794
| -3% | -$14M | 0.01% | 1104 |
|
|
2024
Q4 | $405M | Buy |
19,425,129
+407,638
| +2% | +$8.76M | 0.01% | 1216 |
|
|
2024
Q3 | $378M | Buy |
19,017,491
+322,573
| +2% | +$5.98M | 0.01% | 1262 |
|
|
2024
Q2 | $290M | Buy |
18,694,918
+962,276
| +5% | +$15M | 0.01% | 1369 |
|
|
2024
Q1 | $283M | Buy |
17,732,642
+1,910,343
| +12% | +$28.8M | 0.01% | 1418 |
|
|
2023
Q4 | $266M | Buy |
15,822,299
+439,279
| +3% | +$6M | 0.01% | 1456 |
|
|
2023
Q3 | $180M | Sell |
15,383,020
-468,842
| -3% | -$6.27M | 0.01% | 1606 |
|
|
2023
Q2 | $213M | Buy |
15,851,862
+491,552
| +3% | +$7.07M | 0.01% | 1532 |
|
|
2023
Q1 | $255M | Sell |
15,360,310
-330,016
| -2% | -$5.44M | 0.01% | 1380 |
|
|
2022
Q4 | $292M | Buy |
15,690,326
+421,395
| +3% | +$6.49M | 0.01% | 1242 |
|
|
2022
Q3 | $196M | Buy |
15,268,931
+8,317,115
| +120% | +$98.6M | 0.01% | 1487 |
|
|
2022
Q2 | $48.7M | Sell |
6,951,816
-490,793
| -7% | -$3.6M | ﹤0.01% | 2511 |
|
|
2022
Q1 | $61.7M | Sell |
7,442,609
-242,089
| -3% | -$1.71M | ﹤0.01% | 2459 |
|
|
2021
Q4 | $52M | Sell |
7,684,698
-277,835
| -3% | -$1.83M | ﹤0.01% | 2637 |
|
|
2021
Q3 | $42.2M | Sell |
7,962,533
-43,304
| -0.5% | -$237K | ﹤0.01% | 2768 |
|
|
2021
Q2 | $46M | Sell |
8,005,837
-268,849
| -3% | -$1.39M | ﹤0.01% | 2759 |
|
|
2021
Q1 | $38.1M | Buy |
8,274,686
+530,489
| +7% | +$2.11M | ﹤0.01% | 2798 |
|
|
2020
Q4 | $25.9M | Buy |
7,744,197
+274,900
| +4% | +$924K | ﹤0.01% | 2880 |
|
|
2020
Q3 | $22.2M | Sell |
7,469,297
-167,056
| -2% | -$653K | ﹤0.01% | 2800 |
|
|
2020
Q2 | $35.3M | Sell |
7,636,353
-829,197
| -10% | -$3.73M | ﹤0.01% | 2456 |
|
|
2020
Q1 | $32.6M | Buy |
8,465,550
+20,585
| +0.2% | +$84.5K | ﹤0.01% | 2328 |
|
|
2019
Q4 | $31.7M | Buy |
8,444,965
+189,943
| +2% | +$888K | ﹤0.01% | 2625 |
|
|
2019
Q3 | $43.8M | Buy |
8,255,022
+176,027
| +2% | +$938K | ﹤0.01% | 2376 |
|
|
2019
Q2 | $31M | Buy |
8,078,995
+1,090,271
| +16% | +$4.71M | ﹤0.01% | 2592 |
|
|
2019
Q1 | $35.6M | Buy |
6,988,724
+17,851
| +0.3% | +$52.5K | ﹤0.01% | 2468 |
|
|
2018
Q4 | $13.4M | Buy |
6,970,873
+719,093
| +12% | +$2.06M | ﹤0.01% | 2940 |
|
|
2018
Q3 | $23.6M | Buy |
6,251,780
+192,153
| +3% | +$602K | ﹤0.01% | 2779 |
|
|
2018
Q2 | $18.9M | Buy |
6,059,627
+1,361,096
| +29% | +$4.13M | ﹤0.01% | 2898 |
|
|
2018
Q1 | $11.2M | Buy |
4,698,531
+678,950
| +17% | +$2.26M | ﹤0.01% | 3072 |
|
|
2017
Q4 | $15.7M | Buy |
4,019,581
+298,044
| +8% | +$985K | ﹤0.01% | 2909 |
|
|
2017
Q3 | $9.38M | Buy |
3,721,537
+134,251
| +4% | +$368K | ﹤0.01% | 3201 |
|
|
2017
Q2 | $9.9M | Buy |
3,587,286
+3,034,483
| +549% | +$6.33M | ﹤0.01% | 3175 |
|
|
2017
Q1 | $1.08M | Buy |
+552,803
| New | +$704K | ﹤0.01% | 3799 |
|
|
2016
Q2 | – | Sell |
-3,042
| Closed | -$3K | – | 3725 |
|
|
2016
Q1 | $3K | Buy |
3,042
+1,163
| +62% | +$1.8K | ﹤0.01% | 3404 |
|
|
2015
Q4 | $5K | Hold |
1,879
| – | – | ﹤0.01% | 3136 |
|
|
2015
Q3 | $6K | Hold |
1,879
| – | – | ﹤0.01% | 2933 |
|
|
2015
Q2 | $8K | Buy |
+1,879
| New | +$7.49K | ﹤0.01% | 2911 |
|
Other funds holding CPRX
VCM
DM
VPM
